| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
1 company
Vittal Vasista last filed a Form 4 in March 2024, as Chief Financial Officer at RGNX. From September 2015 to March 2024, the filings on record show 0 open-market purchases and 40 sales. Vittal Vasista's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Vittal Vasista a strong insider score of 79/100, based on 6 past trades. Over a 12-month horizon, all 6 of those trades were profitable, with an average 12-month return of +41.6%.
At the last filing, the largest reported position was 246,534 shares of RGNX. The RGNX filings lean toward selling, a net 385,440 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sale+OE | 7,500 | $40.17 | $301,260.00 | -3.5% | |
| Apr 24, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sale+OE | 15,000 | $40.09 | $601,320.00 | -6.6% | |
| Feb 10, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sale+OE | 14,806 | $50.07 | $741,352.33 | -6.6% | |
| Feb 5, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 300 | $50.00 | $15,000.00 | -0.1% | |
| Jan 17, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 2,394 | $50.00 | $119,700.00 | -1.1% | |
| Jan 8, 2020 | RGNX Regenxbio Inc. | Chief Financial Officer | Sale+OE | 7,500 | $41.75 | $313,152.00 | -3.2% | |
| Mar 21, 2019 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 10,000 | $60.75 | $607,539.00 | -4.2% | |
| Mar 5, 2019 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 3,068 | $60.01 | $184,110.68 | -1.3% | |
| Dec 17, 2018 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 7,500 | $46.35 | $347,650.00 | -5.8% | |
| Nov 15, 2018 | RGNX Regenxbio Inc. | Chief Financial Officer | Sell | 7,500 | $60.29 | $452,206.06 | -5.5% |